JESSICA SENA: Open Payments
NPI 1285162644 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 14 payments from 11 companies in 2025. Trend: 2023 $396 · 2024 $406 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $55 |
| Novo Nordisk Inc | 2 | $42 |
| Amgen Inc. | 1 | $31 |
| Seqirus USA Inc | 1 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Edwards Lifesciences Corporation | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| ABIOMED | 1 | $21 |
| Ossur Americas, Inc. | 1 | $21 |
| Electromed, Inc. | 1 | $19 |
Products named: Ozempic, MOUNJARO, KRYSTEXXA, Fluad, ZENPEP, SAPIEN 3 Ultra RESILIA, Veozah, SMARTVEST.
Industry payments across CO — which companies pay providers there.
